Robert McCutcheon
MRCPsych, PhD
Associate Professor
- Wellcome Clinical Research Career Development Fellow
- Honorary Consultant Psychiatrist
My research focuses on trying to develop better ways of helping people with psychotic disorders like schizophrenia. All current drug treatments work the same way, and while these can help with certain aspects of the disorder, they are ineffective for the cognitive aspects (e.g. problems with memory, planning, and attention) that account for much of the disability associated with the illness.
I undertake studies testing new treatments in both humans and animal models of the illness with the aim of improving cognitive symptoms. In these studies I use techniques such as positron emission tomography and functional MRI to better understand the mechanisms underlying both symptoms and effects of treatment.
I undertook a Chemistry BSc before studying medicine. I then undertook NIHR academic foundation training and clinical fellowship, before completing a Wellcome Clinical PhD fellowship and NIHR academic clinical lectureship during my psychiatric training. My work is now funded by a Wellcome Clinical Research Career Development Fellowship. In addition to colleagues at Oxford I also collaborate closely with researchers at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London.
Recent publications
-
Clozapine monitoring requirements: is it time for an update?
Journal article
Fernandez-Egea E. and McCutcheon RA., (2024), Br J Psychiatry, 1 - 3
-
Menopausal Hormone Therapy for Women With Schizophrenia: What's Stopping Us?
Journal article
Reilly TJ. and McCutcheon RA., (2024), Am J Psychiatry, 181, 854 - 855
-
PsyCog: A computerised mini battery for assessing cognition in psychosis.
Journal article
Gifford G. et al, (2024), Schizophr Res Cogn, 37
-
Corrigendum to "Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis" [Psychoneuroendocrinology 150 (2023) 106049].
Journal article
Aymerich C. et al, (2024), Psychoneuroendocrinology
-
Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis
Journal article
Rogdaki M. et al, (2024), The Lancet Child and Adolescent Health, 8, 510 - 521